Literature DB >> 16115816

The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.

Myriam Fornage1, Craig R Lee, Peter A Doris, Molly S Bray, Gerardo Heiss, Darryl C Zeldin, Eric Boerwinkle.   

Abstract

Stroke is the leading cause of severe disability and the third leading cause of death, accounting for one of every 15 deaths in the USA. We investigated the association of polymorphisms in the soluble epoxide hydrolase gene (EPHX2) with incident ischemic stroke in African-Americans and Whites. Twelve single nucleotide polymorphisms (SNPs) spanning EPHX2 were genotyped in a case-cohort sample of 1336 participants from the Atherosclerosis Risk in Communities (ARIC) study. In each racial group, Cox proportional hazard models were constructed to assess the relationship between incident ischemic stroke and EPHX2 polymorphisms. A score test method was used to investigate the association of common haplotypes of the gene with risk of ischemic stroke. In African-Americans, two common EPHX2 haplotypes with significant and opposing relationships to ischemic stroke risk were identified. In Whites, two common haplotypes showed suggestive indication of an association with ischemic stroke risk but, as in African-Americans, these relationships were in opposite direction. These findings suggest that multiple variants exist within or near the EPHX2 gene, with greatly contrasting relationships to ischemic stroke incidence; some associated with a higher incidence and others with a lower incidence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115816      PMCID: PMC1343524          DOI: 10.1093/hmg/ddi315

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  44 in total

1.  Score tests for association between traits and haplotypes when linkage phase is ambiguous.

Authors:  Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland
Journal:  Am J Hum Genet       Date:  2001-12-27       Impact factor: 11.025

2.  Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocytic epoxyeicosatrienoic Acid.

Authors:  Chenyang Zhang; David R Harder
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

3.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.

Authors:  Kirk E Lohmueller; Celeste L Pearce; Malcolm Pike; Eric S Lander; Joel N Hirschhorn
Journal:  Nat Genet       Date:  2003-01-13       Impact factor: 38.330

4.  An evaluation of measures of synonymous codon usage bias.

Authors:  J M Comeron; M Aguadé
Journal:  J Mol Evol       Date:  1998-09       Impact factor: 2.395

5.  Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.

Authors:  Benjamin B Davis; David A Thompson; Laura L Howard; Christophe Morisseau; Bruce D Hammock; Robert H Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

6.  Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow.

Authors:  N J Alkayed; E K Birks; A G Hudetz; R J Roman; L Henderson; D R Harder
Journal:  Am J Physiol       Date:  1996-10

7.  Robust variance estimation for the case-cohort design.

Authors:  W E Barlow
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

8.  Bone formation in carotid plaques: a clinicopathological study.

Authors:  Jennifer L Hunt; Ronald Fairman; Marc E Mitchell; Jeffrey P Carpenter; Michael Golden; Tigran Khalapyan; Megan Wolfe; David Neschis; Ross Milner; Benjamin Scoll; Anita Cusack; Emile R Mohler
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

9.  Actions of epoxygenase metabolites on the preglomerular vasculature.

Authors:  J D Imig; L G Navar; R J Roman; K K Reddy; J R Falck
Journal:  J Am Soc Nephrol       Date:  1996-11       Impact factor: 10.121

10.  Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats.

Authors:  Myriam Fornage; Cruz A Hinojos; Barbara W Nurowska; Eric Boerwinkle; Bruce D Hammock; Christophe H P Morisseau; Peter A Doris
Journal:  Hypertension       Date:  2002-10       Impact factor: 10.190

View more
  41 in total

1.  Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Craig R Lee; Kari E North; Molly S Bray; Myriam Fornage; John M Seubert; John W Newman; Bruce D Hammock; David J Couper; Gerardo Heiss; Darryl C Zeldin
Journal:  Hum Mol Genet       Date:  2006-04-04       Impact factor: 6.150

Review 2.  Cytochrome P450 eicosanoids and cerebral vascular function.

Authors:  John D Imig; Alexis N Simpkins; Marija Renic; David R Harder
Journal:  Expert Rev Mol Med       Date:  2011-03-01       Impact factor: 5.600

Review 3.  Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Authors:  Sydney Zarriello; Julian P Tuazon; Sydney Corey; Samantha Schimmel; Mira Rajani; Anna Gorsky; Diego Incontri; Bruce D Hammock; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2018-11-14       Impact factor: 11.685

4.  Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury.

Authors:  Myriam Fornage; Thomas H Mosley; Clifford R Jack; Mariza de Andrade; Sharon L R Kardia; Eric Boerwinkle; Stephen T Turner
Journal:  Hum Genet       Date:  2006-09-22       Impact factor: 4.132

5.  Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.

Authors:  Matthias J Merkel; Lijuan Liu; Zhiping Cao; William Packwood; Jennifer Young; Nabil J Alkayed; Donna M Van Winkle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

6.  Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia.

Authors:  Ines P Koerner; Wenri Zhang; Jian Cheng; Susan Parker; Patricia D Hurn; Nabil J Alkayed
Journal:  Front Biosci       Date:  2008-01-01

7.  Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent.

Authors:  Jeffrey J Iliff; Nabil J Alkayed
Journal:  Future Neurol       Date:  2009-03-01

Review 8.  Soluble epoxide hydrolase in atherosclerosis.

Authors:  Yi-Xin Jim Wang; Arzu Ulu; Le-Ning Zhang; Bruce Hammock
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

Review 9.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

10.  Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.

Authors:  Silke Kullmann; Priska Binner; Kirsten Rackebrandt; Andreas Huge; Georg Haltern; Mark Lankisch; Reiner Füth; Eberhard von Hodenberg; Hans-Peter Bestehorn; Thomas Scheffold
Journal:  BMC Cardiovasc Disord       Date:  2009-10-08       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.